Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples
A. Biji, O. Khatun, S. Swaraj, R. Narayan, R. Rajmani, R. Sardar, D. Satish, S. Mehta, H. Bindhu, M. Jeevan, D. K. Saini, A. Singh, D. Gupta, S. Tripathi
This study identifies prognostic markers and therapeutic targets for COVID-19 by analyzing Omics data from nasal and BALF samples, finding S100 family genes and TXN as key factors, and validating Auranofin as a potential treatment.
bioRxiv · Feb 18, 2021Microbiology